BioMerieux Share Holder Equity 2017-2024 | BMXMF

BioMerieux share holder equity from 2017 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • BioMerieux share holder equity for the quarter ending December 31, 2024 was $4.557B, a 21.85% increase year-over-year.
  • BioMerieux share holder equity for 2024 was $4.557B, a 12.21% increase from 2023.
  • BioMerieux share holder equity for 2023 was $4.061B, a 5.81% increase from 2022.
  • BioMerieux share holder equity for 2022 was $3.838B, a 2.19% increase from 2021.
BioMerieux Annual Share Holder Equity
(Millions of US $)
2024 $4,557
2023 $4,061
2022 $3,838
2021 $3,756
2020 $2,834
2019 $2,525
2018 $2,366
2017 $1,963
2016 $1,794
2015 $0
BioMerieux Quarterly Share Holder Equity
(Millions of US $)
2024-12-31 $4,557
2023-12-31 $4,061
2023-06-30 $3,971
2022-12-31 $3,838
2022-06-30 $3,739
2021-12-31 $3,756
2021-06-30 $3,312
2020-12-31 $2,834
2019-12-31 $2,525
2019-06-30 $2,380
2018-12-31 $2,366
2018-06-30 $2,193
2017-12-31 $1,963
2017-06-30 $1,804
2016-12-31 $1,794
Sector Industry Market Cap Revenue
Medical Medical Services $15.985B $4.307B
bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $135.913B 25.22
CVS Health (CVS) United States $77.267B 9.60
Elevance Health (ELV) United States $63.437B 8.53
Cencora (COR) United States $56.784B 19.75
DiDi Global (DIDIY) China $26.545B 28.20
Labcorp Holdings (LH) United States $21.098B 17.11
Natera (NTRA) United States $19.106B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $14.371B 0.00
Medpace Holdings (MEDP) United States $13.731B 35.52
CochLear (CHEOY) Australia $13.060B 0.00
ICON (ICLR) Ireland $13.042B 12.12
Solventum (SOLV) United States $12.616B 13.35
Revvity (RVTY) United States $11.331B 19.50
Viatris (VTRS) United States $10.845B 3.73
Sonic Healthcare (SKHHY) Australia $8.965B 0.00
Avantor (AVTR) United States $8.872B 12.89
HealthEquity (HQY) United States $8.424B 36.90
Charles River Laboratories (CRL) United States $8.024B 15.72
Caris Life Sciences,�Inc (CAI) United States $7.706B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $5.059B 29.79
BrightSpring Health Services (BTSG) United States $3.542B 32.50
Sotera Health (SHC) United States $3.225B 18.32
Surgery Partners (SGRY) United States $2.827B 36.77
Organon (OGN) United States $2.553B 2.71
Concentras Parent (CON) United States $2.534B 14.64
Alignment Healthcare (ALHC) United States $2.441B 0.00
GeneDx Holdings (WGS) United States $2.308B 88.90
Progyny (PGNY) United States $1.970B 43.36
GoodRx Holdings (GDRX) United States $1.757B 35.14
PACS (PACS) United States $1.750B 0.00
Premier (PINC) United States $1.738B 13.19
Ardent Health (ARDT) United States $1.503B 6.41
Teladoc Health (TDOC) United States $1.477B 0.00
Establishment Labs Holdings (ESTA) $1.257B 0.00
Pediatrix Medical (MD) United States $1.094B 8.33
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.902B 0.00
QDM (QDMI) Hong Kong, SAR China $0.846B 290.00
AMN Healthcare Services Inc (AMN) United States $0.763B 7.14
CareDx (CDNA) United States $0.725B 11.32
Embecta (EMBC) United States $0.625B 4.21
Nutex Health (NUTX) United States $0.556B 8.41
So-Young (SY) China $0.541B 0.00
InnovAge Holding (INNV) United States $0.524B 0.00
SBC Medicals (SBC) United States $0.516B 0.00
Omada Health (OMDA) $0.495B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.62
LifeMD (LFMD) United States $0.471B 0.00
Sonida Senior Living (SNDA) United States $0.468B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.414B 0.00
Enhabit (EHAB) United States $0.342B 28.17
Oncology Institute (TOI) United States $0.316B 0.00
Performant Healthcare (PHLT) United States $0.287B 0.00
Beauty Health (SKIN) United States $0.231B 0.00
DocGo (DCGO) United States $0.149B 24.33
Pheton Holdings (PTHL) China $0.148B 0.00
Sera Prognostics (SERA) United States $0.109B 0.00
Ascend Wellness Holdings (AAWH) United States $0.081B 0.00
KindlyMD (NAKA) United States $0.067B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
Biodesix (BDSX) United States $0.053B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.051B 0.00
ModivCare (MODV) United States $0.046B 0.00
Basel Medical Group (BMGL) Singapore $0.041B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.016B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00